ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study

Active, not recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

August 19, 2020

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Neonatal Opioid Withdrawal Syndrome

Trial Locations (6)

Univeristy of Pennsylvania, Philadelphia

Children's National Medical Center, Washington D.C.

RTI International, Durham

University of Alabama at Birmingham, Birmingham

Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland

Cincinnati Children's Medical Center, Cincinnati

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program

NETWORK

NCT04149509 - ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study | Biotech Hunter | Biotech Hunter